These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 34505870)

  • 1. Estimated Savings From International Reference Pricing for Prescription Drugs.
    Mulcahy AW; Schwam D; Rao P; Rennane S; Shetty K
    JAMA; 2021 Nov; 326(17):1744-1745. PubMed ID: 34505870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Why France Spends Less Than the United States on Drugs: A Comparative Study of Drug Pricing and Pricing Regulation.
    Raimond VC; Feldman WB; Rome BN; Kesselheim AS
    Milbank Q; 2021 Mar; 99(1):240-272. PubMed ID: 33751664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fair global drug pricing.
    Campbell JD; Kaló Z
    Expert Rev Pharmacoecon Outcomes Res; 2018 Dec; 18(6):581-583. PubMed ID: 30215535
    [No Abstract]   [Full Text] [Related]  

  • 4. Importing Prescription Drugs from Canada - Legal and Practical Problems with the Trump Administration's Proposal.
    Sachs RE; Bagley N
    N Engl J Med; 2020 May; 382(19):1777-1779. PubMed ID: 32374960
    [No Abstract]   [Full Text] [Related]  

  • 5. An Incomplete Prescription: President Trump's Plan to Address High Drug Prices.
    Sarpatwari A; Avorn J; Kesselheim AS
    JAMA; 2018 Jun; 319(23):2373-2374. PubMed ID: 29800027
    [No Abstract]   [Full Text] [Related]  

  • 6. Drug-Pricing Debate Redux - Should Cost-Effectiveness Analysis Be Used Now to Price Pharmaceuticals?
    Neumann PJ; Cohen JT; Ollendorf DA
    N Engl J Med; 2021 Nov; 385(21):1923-1924. PubMed ID: 34767318
    [No Abstract]   [Full Text] [Related]  

  • 7. International Reference Pricing for Prescription Drugs in the United States: Administrative Limitations and Collateral Effects.
    Rand LZ; Kesselheim AS
    Value Health; 2021 Apr; 24(4):473-476. PubMed ID: 33840424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recommendations for Lowering Prescription Drug Spending in Public Programs.
    Jazowski SA; Dusetzina SB
    Ann Intern Med; 2019 Dec; 171(11):855-856. PubMed ID: 31711129
    [No Abstract]   [Full Text] [Related]  

  • 9. Pursuing Value-Based Prices for Drugs: A Comprehensive Comparison of State Prescription Drug-Pricing Boards.
    Bendicksen L; Rome BN; Avorn J; Kesselheim AS
    Milbank Q; 2021 Dec; 99(4):1162-1197. PubMed ID: 34375015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Future of Drug-Pricing Transparency.
    Feldman WB; Rome BN; Avorn J; Kesselheim AS
    N Engl J Med; 2021 Feb; 384(6):489-491. PubMed ID: 33440087
    [No Abstract]   [Full Text] [Related]  

  • 11. Health and Taxes.
    Cutler DM
    JAMA; 2016 Oct; 316(16):1634-1635. PubMed ID: 27784083
    [No Abstract]   [Full Text] [Related]  

  • 12. How Medicare could get better prices on prescription drugs.
    Outterson K; Kesselheim AS
    Health Aff (Millwood); 2009; 28(5):w832-41. PubMed ID: 19643778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Who benefits from drug discounts? Drugmakers, hospitals battle over indigent-care program.
    Lee J
    Mod Healthc; 2013 Jul; 43(28):8-9. PubMed ID: 24044228
    [No Abstract]   [Full Text] [Related]  

  • 14. Revenues and Profits From Medicare Patients in Hospitals Participating in the 340B Drug Discount Program, 2013-2016.
    Conti RM; Nikpay SS; Buntin MB
    JAMA Netw Open; 2019 Oct; 2(10):e1914141. PubMed ID: 31664442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Policy Recommendations for Pharmacy Benefit Managers to Stem the Escalating Costs of Prescription Drugs: A Position Paper From the American College of Physicians.
    Daniel H; Bornstein SS;
    Ann Intern Med; 2019 Dec; 171(11):823-824. PubMed ID: 31711103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disclosing Prescription-Drug Prices in Advertisements - Legal and Public Health Issues.
    Dusetzina SB; Mello MM
    N Engl J Med; 2018 Dec; 379(24):2290-2293. PubMed ID: 30428275
    [No Abstract]   [Full Text] [Related]  

  • 17. Regulating Drug Prices while Increasing Innovation.
    Conti RM; Frank RG; Gruber J
    N Engl J Med; 2021 Nov; 385(21):1921-1923. PubMed ID: 34767322
    [No Abstract]   [Full Text] [Related]  

  • 18. States on the Front Line: Addressing America's Drug Pricing Problem.
    Riley T; Lanford S
    J Leg Med; 2019; 39(2):81-93. PubMed ID: 31503529
    [No Abstract]   [Full Text] [Related]  

  • 19. The Burden of Federalism: Challenges to State Attempts at Controlling Prescription Drug Costs.
    Gudiksen KL; King JS
    J Leg Med; 2019; 39(2):95-120. PubMed ID: 31503534
    [No Abstract]   [Full Text] [Related]  

  • 20. The Price of Crossing the Border for Medications.
    Fralick M; Avorn J; Kesselheim AS
    N Engl J Med; 2017 Jul; 377(4):311-313. PubMed ID: 28745989
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.